Indeed, TTR, carrier of the thyroid hormone thyroxine (T4) in serum and CSF, is associated with systemic amyloidosis in humans [92], but also with an anti-amyloidogenic effect preventing Aβ deposition in neuronal cell cultures [93]. This evidence concerns the gene TTR and primary systemic amyloidosis.